Oliva Chávez, Adela S. http://orcid.org/0000-0003-2397-0846
Wang, Xiaowei
Marnin, Liron
Archer, Nathan K. http://orcid.org/0000-0002-8212-8985
Hammond, Holly L.
Carroll, Erin E. McClure
Shaw, Dana K. http://orcid.org/0000-0002-5212-2494
Tully, Brenden G.
Buskirk, Amanda D.
Ford, Shelby L.
Butler, L. Rainer
Shahi, Preeti
Morozova, Kateryna
Clement, Cristina C.
Lawres, Lauren
Neal, Anya J. O’ http://orcid.org/0000-0001-5188-1344
Mamoun, Choukri Ben http://orcid.org/0000-0001-5028-1400
Mason, Kathleen L.
Hobbs, Brandi E. http://orcid.org/0000-0001-9246-5486
Scoles, Glen A.
Barry, Eileen M. http://orcid.org/0000-0002-5326-0047
Sonenshine, Daniel E.
Pal, Utpal
Valenzuela, Jesus G.
Sztein, Marcelo B.
Pasetti, Marcela F.
Levin, Michael L.
Kotsyfakis, Michail http://orcid.org/0000-0002-7526-1876
Jay, Steven M. http://orcid.org/0000-0002-3827-5988
Huntley, Jason F.
Miller, Lloyd S.
Santambrogio, Laura http://orcid.org/0000-0002-4674-7041
Pedra, Joao H. F. http://orcid.org/0000-0001-8740-2667
Article History
Received: 14 October 2019
Accepted: 24 May 2021
First Online: 17 June 2021
Competing interests
: L.S.M. is a full-time employee of Janssen Pharmaceuticals and holds Johnson & Johnson stock. L.S.M. performed all work at his prior affiliation at Johns Hopkins University School of Medicine and he has received prior grant support from AstraZeneca, Pfizer, Boehringer Ingelheim, Regeneron Pharmaceuticals, and Moderna Therapeutics. L.S.M. was also a paid consultant for Armirall, AstraZeneca, Moderna Therapeutics and Janssen Research and Development. L.S.M. was on the scientific advisory board of Integrated Biotherapeutics and is a shareholder of Noveome Biotherapeutics. All of these aforementioned companies are developing therapeutics against infections and/or inflammatory conditions. The remaining authors declare not competing interest.